A

ADC Therapeutics SA
D

ADCT

1.70500
USD
-0.06
(-3.40%)
مغلق
حجم التداول
9,014
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
164,855,797
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    C
    CIEN
    6.130
    (6.91%)
    94.860 USD
    CSCO
    CSCO
    0.600
    (0.98%)
    61.620 USD
    DELL
    DELL
    3.520
    (3.15%)
    115.100 USD
    HPE
    HPE
    0.715
    (3.02%)
    24.410 USD
    HPQ
    HPQ
    0.175
    (0.53%)
    33.115 USD
    IBM
    IBM
    -1.020
    (-0.45%)
    223.200 USD
    I
    INFN
    -0.01000
    (-0.15%)
    6.60000 USD
    INTC
    INTC
    0.075
    (0.34%)
    21.855 USD
    J
    JNPR
    0.190
    (0.49%)
    38.770 USD
    NTAP
    NTAP
    2.430
    (1.97%)
    126.040 USD
    المزيد
الأخبار
المقالات

العنوان: ADC Therapeutics SA

القطاع: Healthcare
الصناعة: Biotechnology
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.